LONDON, Aug 14 (Reuters) - Eli Lilly ( LLY ) will raise
the list price in the UK of its weight-loss and type 2 diabetes
treatment Mounjaro by 170% to be in line with other European
markets, the U.S. drugmaker said on Thursday.